Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 3/20 | 0.64 |
| ▸ | FGFR1 | P11362 | 12/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | SRC | P12931 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19228785 | 0.88 | HTT (0.56) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL12135624 | 0.87 | KDR (0.76) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL7677283 | 0.82 | KDR (0.68) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL23099348 | 0.79 | KDR (0.57) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL16656278 | 0.78 | KDR (0.67) | KDRFGFR1HTTSRC | |
| SCHEMBL7679742 | 0.78 | KDR (0.64) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL5942362 | 0.78 | FGFR1 (0.79) | KDRFGFR1SRCALDH1A1 | |
| SCHEMBL7683792 | 0.78 | KDR (1.00) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL27285256 | 0.78 | KDR (0.63) | KDRFGFR1HTTSRCALDH1A1 | |
| SCHEMBL23189498 | 0.77 | KDR (0.44) | KDRFGFR1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11545637-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| US-20220302396-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2022-09-22 | — | — | US | disclosed |
| US-20220127291-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-28 | — | — | US | disclosed |
| US-10957866-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-23 | — | — | US | disclosed |
| US-10897016-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-01-19 | — | — | US | disclosed |
| US-20180212163-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-07-26 | — | — | US | disclosed |
| US-20180138425-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180212163-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | KDR 925/4885FGFR1 2905/4885HTT 2520/4885 |
| US-20180138425-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | DDT, OCIAD1, OCIAD2 | KDR 2567/4885FGFR1 2938/4885HTT 1372/4885 |
| US-11545637-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, ICOSLG | KDR 925/4885FGFR1 2905/4885HTT 2520/4885 |
| US-10897016-B2 | Organic electroluminescent materials and devices | DDT, OCIAD1, OCIAD2 | KDR 2567/4885FGFR1 2938/4885HTT 1372/4885 |
| US-10957866-B2 | Organic electroluminescent materials and devices | TYR, YAP1, PAXBP1 | KDR 907/4885FGFR1 1295/4885HTT 2837/4885 |
| US-20220127291-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RER1, OCIAD2, OXSR1 | KDR 672/4885FGFR1 1800/4885HTT 3434/4885 |
| US-20220302396-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | JUND, DRD2, DRD1 | KDR 488/4885FGFR1 963/4885HTT 670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.